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Introduction
The effectiveness of anthracycline chemotherapy is lim-
ited by dose dependant cardiotoxicity. Current protocols
reduce the cumulative dose, however subclinical myo-
cardial damage may still manifest years after cessation
of therapy. The most serious side effect is dilated cardi-
omyopathy with pathological changes of fibrosis. The
potential presence of fibrosis in this remodelling is
unknown.
Purpose
The aim of this study was to use cardiac MRI to charac-
terize subclinical cardiac abnormalities (changes in left
ventricular (LV) morphology and extent of diffuse fibro-
sis) in childhood cancer survivors.
Methods
Patients with previous anthracycline therapy for child-
hood cancer and in remission for at least 2 years under-
went cardiac MRI on a 1.5T Siemens Sonata scanner to
assess LV function and mass (indexed to body surface
area). Changes in myocardial T1 values from baseline to
15 minutes post bolus injection of Gd-DTPA (0.125
mmol/kg) was used to estimate the tissue concentration
of contrast, reflecting diffuse fibrosis ([Gd ]= {1/T1
(15 min) - 1/T1 (baseline)}/4.35, in mmol). Myocardial
T1 values were quantified in 3 mid-ventricular short
axis slices using a custom saturation recovery single
shot SSFP pulse sequence with 10 saturation recovery
times spanning the cardiac cycle, acquired in one
breath-hold per slice. Myocardium was segmented using
a modified AHA format with triple the circumferential
resolution and mean signal intensities were fitted to a 3
parameter saturation recovery curve. Data was presented
as median with ranges and analysed using Spearman’s
correlation coefficient and Wilcoxon rank sum tests
(p<0.05).
Results
Thirteen patients (median age: 14 years, range: 9-18
years), were studied 10 years (3-12 years) after complet-
ing chemotherapy (anthracycline dose 210 mg/m
2, range
80-375 mg/m
2). Subjects had normal EDV 67.6 ml/m
2
(56-114 ml/ m
2), increased ESV 36.3 ml/m
2 (23-60
ml/m
2) and normal EF (63%, range 54-74%) when com-
pared to normal reported values in children. Ventricular
volumes increased with time post chemotherapy (EDV,
r=0.78, p<0.01 and ESV, r=0.63, p=0.02) (Figure 1).
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mal range, 6-7 years post chemotherapy. Degree of
fibrosis [Gd] negatively correlated with mass/volume
ratio (r=-0.8, p<0.01), (Figure 2). There was no relation-
ship between anthracycline dose and ventricular func-
tion or fibrosis.
Conclusion
In children with previous anthracycline exposure, diffuse
fibrosis as indicated by a larger myocardial concentration
of Gd-DTPA was associated with ventricular dilatation
without a corresponding increase in mass, (decreased
mass/volume ratio). Ventricular dilatation progresses
with time post therapy with larger than average values at
approximately 6-7 years from chemotherapy.
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